Analyst consensus rating
Pharming Group Analyst Rating: Strong Buy
Direct answer
Pharming Group's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $35.70.
Forecast evidence checked November 12, 2026.
Get free Pharming Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.40
- Average price target
- $35.70
- High price target
- $41.00
- Low price target
- $25.80
- Low target gap
- +92.5%
- Target upside
- +166.4%
- High target gap
- +206%
- Target range width
- 113.4%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Pharming Group?
Pharming Group has a verified Strong Buy consensus. The same dataset has an average price target of $35.70.
How far are Pharming Group's low and high targets from the recorded price?
The low target implies +92.5%, while the high target implies +206%.
How many analysts are included in Pharming Group's consensus?
The verified consensus includes 4 analysts.
How is Pharming Group's target upside or downside calculated?
The average target of $35.70 is divided by the recorded price of $13.40, then one is subtracted to produce +166.4%. This does not guarantee a future return.
When was Pharming Group's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.